Fresenius Medical Care AG Company Information
Fresenius Medical Care AG's employee growth, exchange listings and data sources
Key Information
- Name: Fresenius Medical Care AG
- Ticker: FME
- Exchange: SWX
- Founded: 1996
- Industry: Health Care Services
- Sector: Healthcare
- Market Cap: €9.894b
- Listing Market Cap: €9.411b
- Shares Outstanding: 293.41m
- Website: https://www.freseniusmedicalcare.com
Number of Employees
Location
- Fresenius Medical Care AG
- Else-KrOener-Strasse 1
- Bad Homburg
- Hessen
- 61352
- Germany
Listings
| Ticker | Exchange | Primary Security | Security Type | Country | Currency | Listed on |
|---|---|---|---|---|---|---|
| FMS | NYSE (New York Stock Exchange) | SPON ADR-EACH REP 0.5 NPV | US | USD | Sep 1996 | |
| FMEA | DB (Deutsche Boerse AG) | SPON ADR-EACH REP 0.5 NPV | DE | EUR | Sep 1996 | |
| FMCQ.F | OTCPK (Pink Sheets LLC) | Yes | Ordinary Shares | US | USD | Oct 1996 |
| FME | DB (Deutsche Boerse AG) | Yes | Ordinary Shares | DE | EUR | Oct 1996 |
| 0H9X | LSE (London Stock Exchange) | Yes | Ordinary Shares | GB | EUR | Oct 1996 |
| FME | XTRA (XETRA Trading Platform) | Yes | Ordinary Shares | DE | EUR | Oct 1996 |
| FMED | BATS-CHIXE (BATS 'Chi-X Europe') | Yes | Ordinary Shares | GB | EUR | Oct 1996 |
| FME | BRSE (Berne Stock Exchange) | Yes | Ordinary Shares | CH | CHF | Oct 1996 |
| FME | WBAG (Wiener Boerse AG) | Yes | Ordinary Shares | AT | EUR | Oct 1996 |
| FME N | BMV (Bolsa Mexicana de Valores) | Yes | Ordinary Shares | MX | MXN | Oct 1996 |
| FME | SWX (SIX Swiss Exchange) | Yes | Ordinary Shares | CH | CHF | Oct 1996 |
| 1FME | BIT (Borsa Italiana) | Yes | Ordinary Shares | IT | EUR | Oct 1996 |
| FME | BUL (Bulgaria Stock Exchange) | Yes | Ordinary Shares | BG | EUR | Oct 1996 |
| FMSC34 | BOVESPA (Bolsa de Valores de Sao Paulo) | BDR EACH REPR 1 ADR | BR | BRL | Sep 2022 |
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/08/20 16:36 |
| End of Day Share Price | 2024/08/20 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/08/20 16:36 |
| End of Day Share Price | 2024/08/20 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Fresenius Medical Care AG is covered by 59 analysts. 18 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Martin Schnee | AlphaValue |
| Brian Williams | Avondale Partners |
| Olav Zilian | Baader Helvea Equity Research |